You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
First‐line drugs for hypertension
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2009
|
| DOI | 10.1002/14651858.cd001841.pub2 |
| Pubmed ID | |
| Authors |
James M Wright, Vijaya M Musini |
| Abstract |
Sustained elevated blood pressure, unresponsive to lifestyle measures, leads to a critically important clinical question: What class of drug to use first-line? This review answers that question. |
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 11% |
| Canada | 2 | 11% |
| United Kingdom | 1 | 6% |
| Japan | 1 | 6% |
| Saudi Arabia | 1 | 6% |
| New Zealand | 1 | 6% |
| Iraq | 1 | 6% |
| Nepal | 1 | 6% |
| Unknown | 8 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 13 | 72% |
| Scientists | 3 | 17% |
| Practitioners (doctors, other healthcare professionals) | 1 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 204 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 2% |
| Japan | 2 | <1% |
| South Africa | 1 | <1% |
| United Kingdom | 1 | <1% |
| Peru | 1 | <1% |
| Sweden | 1 | <1% |
| Egypt | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 192 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 36 | 18% |
| Student > Bachelor | 27 | 13% |
| Student > Ph. D. Student | 24 | 12% |
| Researcher | 23 | 11% |
| Other | 15 | 7% |
| Other | 50 | 25% |
| Unknown | 29 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 126 | 62% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 5% |
| Agricultural and Biological Sciences | 10 | 5% |
| Nursing and Health Professions | 6 | 3% |
| Chemistry | 4 | 2% |
| Other | 16 | 8% |
| Unknown | 31 | 15% |
Attention Score in Context
This research output has an Altmetric Attention Score of 36. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 September 2019.
All research outputs
#1,157,143
of 25,923,151 outputs
Outputs from Cochrane database of systematic reviews
#2,261
of 13,163 outputs
Outputs of similar age
#3,194
of 123,595 outputs
Outputs of similar age from Cochrane database of systematic reviews
#8
of 71 outputs
Altmetric has tracked 25,923,151 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,163 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 123,595 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.